Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …

The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike
glycoprotein to its cellular receptor, the angiotensin-converting enzyme 2 (ACE2), causes its …

Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

Antibodies against two G-protein coupled receptors (GPCRs), angiotensin II type 1 receptor
(AT1R) and endothelin A receptor (ETAR) are among a growing number of autoantibodies …

CTL-mediated killing of virally infected or malignant cells is orchestrated at the immune
synapse (IS). We hypothesized that SARS-CoV-2 may target lytic IS assembly to escape …

Severe acute respiratory coronavirus 2 (SARS-CoV-2) infection in the young and healthy
usually results in an asymptomatic or mild viral syndrome, possibly through an erythropoietin …

Angiotensin II type 1 receptor antibodies (AT1R-Ab) are among the most investigated types
of non-HLA antibodies in kidney transplantation. Our aim is to provide an update regarding …

Angiotensin II (Ang II) is formed by the action of angiotensin-converting enzyme (ACE) in the
renin–angiotensin system. This hormone is known to induce cardiac hypertrophy and heart …

This review outlines the propensity for metabolic syndrome (MetS) to induce elevated
disease severity, higher mortality rates post-infection, and poor vaccination outcomes for …

Human infection by the SARS-CoV-2 is causing the current COVID-19 pandemic. With the
growing numbers of cases and deaths, there is an urgent need to explore …